Levetiracetam Tablet, Film Coated
Product Images NDC 68788-8254

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 68788-8254). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levetiracetam Tab Usp 500mg (E31c6830 4647 4481 B4f1 494a52c48b1b 00)

Levetiracetam Tab USP 500 mg film-coated tablets label showing branding for Preferred Pharmaceuticals, Inc. The label includes dosage form, strength, storage instructions, barcode, and space for prescription and batch information. Directions for use are provided in English and Spanish on a yellow background.*

FDA Label Image

Figure 1 (E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 01)

A formula showing calculation for total daily dose in mL/day based on daily dose in mg/kg/day multiplied by patient weight in kg, divided by 100 mg/mL. This appears to be part of dosing instructions or a calculation guide for Levetiracetam oral solution.*

FDA Label Image

Figure 2 (E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 02)

A text panel showing formulas for calculating creatinine clearance (CLcr). It includes the adjustment for female patients and body surface area (BSA) to determine CLcr in mL/min/1.73 m² based on age, weight, serum creatinine, and BSA subject values.*

FDA Label Image

Structure (E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 03)

Chemical structure of levetiracetam, showing a pyrrolidone ring attached to an ethyl group and an amide functional group.*

FDA Label Image

Figure 4 (E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 04)

A vertical bar chart showing the percentage of patients across three groups: Placebo (7.4%), Levetiracetam 1000 mg/day (37.1%), and Levetiracetam 3000 mg/day (39.6%). The y-axis represents the percent of patients, ranging from 0% to 45%, while the x-axis categorizes the treatment groups with patient counts indicated below each label.*

FDA Label Image

Figure 5 (E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 05)

A bar chart depicting the percentage of patients experiencing an outcome across three groups: Placebo (6.3%), Levetiracetam 1000 mg/day (20.8%), and Levetiracetam 2000 mg/day (35.2%). The y-axis represents the percentage of patients, while the x-axis lists the treatment groups with sample sizes indicated.*

FDA Label Image

Figure 6 (E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 06)

A bar graph depicting the percentage of patients for two groups: Placebo (N=104) and Levetiracetam 3000 mg/day (N=180). The Levetiracetam group shows a higher percentage at 39.4%, compared to 14.4% for the Placebo group. The y-axis represents the percentage of patients, ranging from 0% to 45%.*

FDA Label Image

Figure 7 (E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 07)

A bar chart comparing the percentage of patients in two groups: Placebo (N=97) and Levetiracetam (N=101). The y-axis represents the percentage of patients, with Placebo at 19.6% and Levetiracetam at 44.6%, indicating a higher patient percentage in the Levetiracetam group.*

FDA Label Image

Figure 8 (E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 08)

A bar chart comparing the percentage of patients in two groups: Placebo (N=51) and Levetiracetam (N=58). The y-axis represents the percentage of patients, ranging from 0% to 45%. The Placebo group shows 19.6%, while the Levetiracetam group shows 43.1%. Asterisk marks the Levetiracetam bar indicating statistical notation.*

FDA Label Image

Figure 9 (E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 09)

A bar chart comparing the percentage of patients between placebo and Levetiracetam groups. The placebo group (N=84) shows 45.2%, and the Levetiracetam group (N=79) shows 72.2% with an asterisk above, indicating statistical significance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.